OncLive
Advertisement
Articles by OncLive
Advertisement
Latest Updated Articles
Bridging Data and Expert Insights: Paving the Way for Improved CLL OutcomesPublished: March 10th 2025 | Updated: April 25th 2025
Targeted Therapies for CLL: Managing Adverse EventsPublished: December 6th 2021 | Updated:
Bridging Data and Expert Insights: Paving the Way for Improved CLL OutcomesPublished: March 10th 2025 | Updated: April 25th 2025
Diagnostic Criteria Used in Differentiated Thyroid CancerPublished: December 17th 2021 | Updated:
Approaches to Initiating Therapy for a Patient With CLL and Worsening SymptomsPublished: December 6th 2021 | Updated:
RAI-Refractory Differentiated Thyroid CancerPublished: December 17th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5

